2010 2015 DEA Safety 
Cannabis Law Report
APRIL 8, 2022
Later that year, Doblin sued the DEA for the first time. The FDA formally decided to open the door to psychedelic research in human participants, and later accepted MAPS’ Phase 1 MDMA safety and tolerance study protocol. submitted his first DEA application to manufacture marijuana for use in medical research.
Cannabis Law Report
SEPTEMBER 23, 2019
Therefore, the AAFP advocates for further research into the overall safety and health effects of recreational use, as well as the effects of those laws on patient and societal health. The AAFP supports requirements testing current marijuana and cannabinoid products for safety, dosing, and product consistency. In the Exam Room.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Joint Blog
JUNE 2, 2020
In his last presidential campaign in 2015, he recognized the medicinal benefits of cannabis but not its adult use. “I He voiced the long-debunked theory in 2010 that marijuana serves as a “gateway drug” to dangerous substances. The issue of legalization is left to the state, taking the health and safety of the public into account.
Meadow
JULY 13, 2018
I don’t know if folks in this space are familiar at all with the 2015 Ohio initiative but it wasn’t a good initiative. We’ve had a cap on that really since 2010 and one way or another, we’ve codified that now to a number of 30. Originally from Virginia, but moved to Ohio at 16. It’s every square inch of it.
Cannabis Law Report
MARCH 25, 2019
The DEA has made previous requests–in 2001 and 2006–to the FDA for an evaluation of marijuana. But DEA regulators determined after both of those reviews that marijuana should remain a Schedule I substance. ii] See How to reschedule marijuana, and why it’s unlikely anytime soon , The Brookings Institution [2015].
Expert insights. Personalized for you.
52 
Let's personalize your content